{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-312734","form_type":"8-K","ticker":"OFIX","cik":"0000884624","company_name":"Orthofix Medical Inc.","filed_at":"2022-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.855862+00:00","generated_at":"2026-06-20T23:12:02.120641+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Orthofix supplements SeaSpine merger disclosures with updated DCF and synergy projections","bullets":["Perella Weinberg DCF analyses updated: discount rates 9.75%-10.75%, perpetuity growth 3.0% for synergies.","SeaSpine standalone DCF range $2.93-$6.52 per share vs implied merger consideration $7.64 (Piper Sandler).","Orthofix standalone DCF range $18.15-$30.17 vs Orthofix closing price $18.34.","Piper Sandler fee estimated ~$4.3M contingent on deal closing; $1M opinion fee already paid.","Projected cost synergies: $42M in 2025E, rising to $50M in 2031E; stock-based comp synergies $8M in 2025E."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-312734","json":"https://secwatch.observer/filing/0001193125-22-312734.json","markdown":"https://secwatch.observer/filing/0001193125-22-312734.md","text":"https://secwatch.observer/filing/0001193125-22-312734.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/884624/000119312522312734/0001193125-22-312734-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/884624/000119312522312734/d398453d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T23:12:02.120641+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}